Gyumri Hosts Exhibition About Armenian Currency And Money Turnover

YEREVAN, October 12, /ARKA/. Armenia’s Central Bank has opened an exhibition in Armenia’s second largest town of Gyumri dedicated to Armenia’s national currency and money turnover’s history. A pres release by the bank said the exhibition will run through October 21.

The opening ceremony was attended Ashot Mkrtchian, a Central Bank board member, who said the goal is to give residents of the town an opportunity to learn about Armenia’s national currency, the dram, the history of money turnover and the performance of the Central Bank.

The press release said local authorities have promised to organize visits of school students to the exhibition. Similar exhibitions were already held in several Armenian regions and in Nagorno-Karabakh. -0-

spot_img

POPULAR

US dollar, euro, and ruble up against  Armenian dram

YEREVAN, August 20. /ARKA/. The average market exchange rate for the US dollar to the Armenian dram on the Armenian foreign exchange market as of August 20, 2026, increased by 0.3 points to 365.26 drams compared to August 19.

Armenia’s public debt will remain stable at just above 40% in the medium term – S&P

Armenia's public debt (excluding liquid assets) will remain broadly stable at just above 40% of GDP in the medium term, according to a report from the international rating agency S&P Global Ratings.

Armenian dram weakened against the dollar and strengthened against the euro and ruble: Central Bank

The average market exchange rate for the US dollar to the Armenian dram, formed on the Armenian foreign exchange market as of August 24, 2026, increased by 0.22 points to 365.38 drams compared to August 21.

S&P: Armenia’s banking sector is well capitalized and highly profitable

Armenia's banking sector remains well capitalized and highly profitable, supported by high net interest income and robust economic growth, according to a report from international rating agency S&P Global Ratings.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img